Document ID: chunk:federal_register_of_legislation:F2023L00016:clause:1_1:p3
Version: federal_register_of_legislation:F2023L00016
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 3/3)
Character Range: 33422–34858

diseases means:
(a)          ankylosing spondylitis or another autoimmune inflammatory spondyloarthritis;
(b)          atopic dermatitis;
(c)          Behçet's disease;
(d)          coeliac disease;
(e)           giant cell arteritis;
(f)           inflammatory bowel disease;
(g)          polymyalgia rheumatica;
(h)          psoriasis;
(i)             rheumatoid arthritis;
(j)            systemic lupus erythematosus; or
(k)           systemic sclerosis (scleroderma).
                                     subclinical hyperthyroidism means having normal free thyroxine (FT4) and total triiodothyronine (T3) levels in conjunction with a thyrotropin (TSH) level persistently below the normal range in the absence of factors known to suppress TSH.
                                     terminal event means the proximate or ultimate cause of death and includes the following:
         (a)           pneumonia;
         (b)           respiratory failure;
         (c)           cardiac arrest;
         (d)           circulatory failure; or
         (e)           cessation of brain function.
                                     valvular heart disease means haemodynamically significant stenosis or incompetence of one or more cardiac valves.
Note: An example of a cause of haemodynamically significant valvular heart disease is rheumatic heart disease.
                                     VEA means the Veterans' Entitlements Act 1986.